Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (9)

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

  2. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

2016

  1. Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators

    BioFactors, Vol. 42, Núm. 6, pp. 600-611

2014

  1. Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat

    DMM Disease Models and Mechanisms, Vol. 7, Núm. 1, pp. 129-141

2012

  1. The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats

    Diabetes, Obesity and Metabolism, Vol. 14, Núm. 3, pp. 234-243

  2. Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074

2011

  1. Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake

    Neuropharmacology, Vol. 60, Núm. 4, pp. 593-601

  2. Role for the putative cannabinoid receptor GPR55 in the islets of Langerhans

    Journal of Endocrinology, Vol. 211, Núm. 2, pp. 177-185

2008

  1. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction

    Journal of Psychiatric Research, Vol. 42, Núm. 4, pp. 278-288